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Increased expression of monocyte chemoattractant protein-i in anti-
thymocyte antibody-induced glomerulonephritis. The infiltration of
monocytes-macrophages in the glomerulus is one of the hallmarks of
glomerulonephritis and may play an important pathogenetic role.
Monocyte chemoattractant protein-i (MCP-i) and colony stimulating
factor-i (CSF-l) are monocyte-specific cytokines with chemoattractant
and activating activities for monocytes. MCP-l and CSF-l can be
generated by several cell types, including glomerular mesangial cells,
and can be stimulated by cytokines and immune complexes. To study
the expression of CSF-l and MCP-l in a model of proliferative
glomerulonephritis we used Northern blot analysis and immuno-histo-
chemistry. The glomerular lesion was induced in rats by the i.v.
injection of a heterologous anti-thymocyte antiserum (ATS), directed
against an antigen which is localized on glomerular mesangial cells.
Northern blot analysis revealed comparable amounts of CSF- I in
glomeruli isolated from control untreated rats, and from rats after 30
minutes to three weeks of injection of ATS antibody. In control
glomeruli no mRNA levels for MCP-i were detectable, but increased
markedly 30 minutes after the induction of the nephritis, were then
reduced at 24 hours and increased again at 5 and 21 days after induction
of the disease. The increase in mRNA levels for MCP-l 30 minutes or
24 hours after ATS injection was markedly attenuated if rats were
complement depleted by cobra venom injection. These time points
following antibody injection were associated with mesangial immune
complex formation (30 mm), mesangiolysis (24 hr) and proliferative
glomerulonephritis (5 and 21 days). By immunohistology the presence
of MCP-l was demonstrated in glomeruli with a predominant mesangial
distribution. The mesangial immunofluorescence for MCP-l followed a
pattern similar to that of the mRNA for MCP-l after induction of the
disease process, that is, it increased after 30 minutes, decreased after 24
hours and was increased again at three weeks. Within 30 minutes of the
antibody injection an increased infiltration of monocytes-macrophages
was observed in the glomeruli, which was maintained up to three weeks
of induction of the glomerulonephritis. When the rats were decomple-
mented with cobra venom factor prior to the i.v. injection of ATS, the
expression of MCP-l in glomeruli remained low and the influx of
monocytes/macrophages did not appear. We conclude that MCP-l is
increased early on in glomeruli of rats with immune-mediated mesangial
proliferative glomerulonephritis. This increase is mediated by comple-
ment activation secondary to the in situ immune complex formation at
the glomerular mesangium. Elevated MCP- I might play an important
role in the recruitment of monocytes/macrophages into glomeruli fol-
lowing in situ immune complex formation.
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There is increasing evidence that monocytes/macrophages
play a major role in the pathogenesis of glomerular diseases [1,
2]. Activated intraglomerular monocytes can participate in the
glomerular inflammatory process and the altered glomerular
function by secretion of a number of mediators of inflammation
such as reactive oxygen species [3, 4], eicosanoids [3, 4],
leukotrienes [5] and platelet activating factor [5]. The interac-
tion of macrophages with glomerular endothelial and mesangial
cells also results in the release of procoagulant activity [61,
cytokines such as interleukin I, TNF-alpha, TGF-beta and
collagenase, which are involved in the remodeling of extracel-
lular matrix and the hypercellularity of glomerular diseases
[7—9]. In the model of anti-thymocyte antiserum (ATS)-induced
in situ immune complex glomerulonephntis, experimental evi-
dence supports major pathophysiological roles for platelet-
derived growth factor (PDGF) and transforming growth factor
TGF-beta generation [10—12].
The mechanisms by which bone marrow-derived monocytes
infiltrate the glomerulus in immune disease remains to be fully
defined, but is likely to involve a combination of chemoattrac-
tants and adhesion molecules [1]. Recently a group of small
early response genes has been described [13]. This cytokine
family includes the monocyte chemoattractant protein-I
(MCP- 1) which corresponds to the product of the JE gene in the
mouse [14, 15]. MCP-1 is a chemoattractant and activating
peptide with a high degree of specificity for monocytes [16]. As
such, MCP-l may play a selective role in the recruitment of
monocytes/macrophages into injured tissues [14, 17, 18].
MCP-i has been purified and cloned from mouse, rat and
human tissue [15—17]. Its expression can be regulated by
cytokines in several cell types including endothelial cells,
vascular smooth muscle cells, and mouse and human mesangial
cells [19—221. Another monocyte specific cytokine is colony
stimulating factor-l (CSF-l). CSF-1 is required for the survival,
proliferation and activation of monocytes including resident
macrophages [23—26]. Generation of both MCP-i and CSF-l
can be regulated by cytokines in cultured mouse and human
mesangial cells [20, 27]. Furthermore, the expression of CSF-1
and MCP- 1 is increased by IgG immune complexes in mesangial
cells, which suggests that these cytokines could also be opera-
tive in glomerular immune complex disease [20]. Finally, gen-
eration of reactive oxygen species under the above condition
may represent the common cellular signal for MCP-l and CSF-l
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expression [28]. In this context it is of interest that the model of
mesangioproliferative glomerulonephritis resulting from the for-
mation of in situ immune complexes between an antigen ex-
pressed on the surface of rat mesangial cells and an injected
antibody [29] is associated with the generation of numerous
cytokines and mediators of inflammation including reactive
oxygen species [4, 10, 11, 30, 31]. Among the cytokines PDGF
has been implicated in the mesangial cell proliferation following
the initial mesangiolysis [10, 11] while TGF-beta may contribute
to the expansion of mesangial matrix [12]. We have recently
demonstrated that this model results in complement-dependent
generation of reactive oxygen species and intragiomerular ac-
cumulation of macrophages which may participate in the for-
mation of inflammatory mediators and the glomerular injury of
this model [4, 30]. Since mesangial cells can generate MCP-l
and CSF- 1, we wondered whether ATS induced glomerulone-
phritis would alter the expression of these monocyte-specific
cytokines and be associated with monocyte accumulation in the
glomeruli. Our experiments reveal increased mRNA levels for
MCP-l in glomeruli isolated from rats after 30 minutes of
injection of ATS. This is also associated with the intraglomer-
ular presence of MCP-l as evidenced by immunohistology.
These data are consistent with the hypothesis that expression of
MCP- 1 in glomeruli of nephritic rats may play a role in the
recruitment of monocytes/macrophages to the site of the im-
mune injury in the glomerulus.
Methods
Induction of glomerulonephritis
Immune-mediated mesangial cell injury was induced in white
male Wistar rats (180 to 200 g body wt) by the i.v. injection of
0.5 ml/100 g body wt of an IgG preparation of a rabbit anti-rat
thymocyte serum (ATS). ATS was induced in New Zealand
rabbits by repeated immunization with thymocytes from Lewis
rats [30]. The IgG preparation of the rabbit serum was made by
caprylic acid precipitation [32]. The specificity of the antibodies
was tested in vitro and in vivo for their reactivity with mesangial
cells. Details of the characterization of the antisera were
described earlier [30, 31]. The glomerulonephritis which devel-
ops after the antibody is characterized by an initial mesangio-
lysis followed by mesangial cell proliferation and an increase in
extracellular matrix appearance [30, 31]. The morphologic and
functional characteristics of this glomerular lesion have been
described earlier [30, 31]. Control animals were injected with a
non-antibody IgG preparation as outlined earlier [30].
To evaluate the effect of the induction of the glomerular
lesion on the expression of MCP-1 and CSF-l, kidneys were
removed 30 minutes, 24 hours, 5 days and 21 days after the
antibody injection (N = 5 rats for each time point). Two series
of experiments with N = 5 animals for each time point were
carried out. Glomeruli were isolated by a fractional sieving
technique as described earlier [30]. The yield and purity of
glomeruli isolated at each time point were comparable (purity
greater than 90%). Glomeruli of rats which received non-
antibody IgG served as controls. To evaluate the possible role
of the complement system, rats (N 5 each group) were treated
with cobra venom factor (Calbiochem, USA) 7.5 z/l00 g body
wt i.p./12 hours prior to the injection of the antibody. Immedi-
ately before antibody injection blood was collected for evalua-
tion of CH5O activity according to Mayer [33]. The analysis
revealed that all CVF treated animals had CH5O levels which
were < 1% of the controls. Kidneys were removed 30 minutes
and 24 hours after induction of the disease for isolation of RNA
and immunohistology.
Glomerular cell suspension
Glomerular cell suspensions of isolated glomeruli were ob-
tained by enzymatic digestion of the isolated glomeruli. For this
purpose an enzyme solution was prepared as follows: 1 mg/mi
of trypsin (Sigma, Munchen, Germany), 1 mg/mI of collagenase
(Seromed, Berlin, Germany) and 0.05 mg/mi of DNAse (Sigma)
were dissolved in Mg2 and Ca2 free PBS. Fifty milliliters of
this enzyme solution are necessary for the cell suspension of
glomeruli from 10 kidneys. Glomeruli were incubated with this
solution for 30 to 40 minutes in a water bath at 37°C under
constant shaking. The preparation was centrifuged for 10 min-
utes at 2000 rpm and the supernatant was removed. The pellet
was washed three times with 35 ml of ice-cold PBS, centrifuged
and the supernatants were removed. The pellet was aspirated
and released over 10 minutes in a 100 sl Eppendorf pipette to
obtain a glomerular cell suspension, which was controlled by
light microscopy. Glomerular cell suspensions were used, since
in pilot studies in our hands the yield of RNA isolation was
better compared to whole glomeruli (4 to 5 tg RNAlkidney
from cell suspensions versus 1 to 2 g RNAfkidney from whole
glomeruli). To test the possibility that the experimental data
might be influenced due to RNA extraction from glomerular cell
suspensions, one set of experiments was performed with whole
glomeruli from control rats and rats 30 minutes following ATS.
The data are presented in Figure lD and reveal that there were
no differences in the expression of mRNA between both tech-
niques.
To characterize the glomerular cell populations in normal and
diseased glomeruli with respect to mesangial and epithelial
cells, isolated cell suspensions were centrifuged in a cytocen-
trifuge. Air dried slides were either stained with ATS (to
characterize mesangial cells) or with a monoclonal mouse
anti-epithelial cell antibody (supplied by Dr. P. Mundel, Heidel-
berg, Germany) [34], or ED-l (to characterize monocytes/
macrophages). The cell preparations were developed by the
APAAP method as described by Cordell et al [35] using
standard kits from Dakopatts (Hamburg, Germany). Two dif-
ferent preparations of each time point were evaluated; 600 cells
per slide were counted in a blinded fashion and the positive cells
were expressed in the percent of the total number of cells
counted.
Isolation of total RNA and Northern blot hybridization
Cellular RNA from glomerular cell suspensions and whole
glomeruli was isolated by the guanidinium isothiocyanate
method [36]. RNA (20 g) was electrophoresed through a 1.2%
agarose gel containing 2.2 M formaldehyde. Equal loading of
lanes was evaluated by ethidium bromide staining of the 18 and
28S RNA. The RNA was transferred to nylon membranes
(Zetabind, Cuno, Meriden, Connecticut, USA) by vacuum
blotting, and UV cross-linked. The cDNA probes for CSF-1
[24] and JE/MCP-l [37] were used for hybridization after
[35P]dCTP-labeling by random oligonucleotide priming of the
cDNA inserts (for JE/MCP- 1 a 577 bp Eco-R 1 fragment and for
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CSF-1 a 2.1 kb Eco-R 1 fragment). The filters were washed to a
final high stringency in 0.1 x SSPE/l.0%SDS(i X SSPE = 0.18
M NaCl/10 m sodium phosphate, pH 7.4/1 mart EDTA) for 30
to 60 minutes at 65°C. Autoradiography was performed with the
intensifying screen at —70°C for appropriate time periods. The
size of the respective RNA was identified by comparison of its
mobility with the ethidium bromide-stained RNA standards.
The membranes were rehybridized with a cDNA probe coding
for the gene glyceraldehyde-3-phosphate dehydrogenase [381 to
account for small loading and transfer variations. Exposed films
were scanned with a laser densitometer (Hoefer Scientific
Instruments, San Francisco, California, USA) and relative
RNA levels were calculated.
Immunohistology
Renal tissue was obtained from control and nephritic animals
(N = 5 rats for each time point) for immunofluorescence
staining of MCP-l and macrophages.
The tissue was frozen in liquid nitrogen and cut sections were
stained with a 1:100 dilution of a mouse monoclonal antibody
directed against human MCP-l (a gift from T. Yoshimura,
Laboratory of Immunobiology, National Cancer Institute, Be-
thesda, Maryland, USA). The cross reactivity of this antibody
with deposited ATS was excluded by the negative stain of CVF
treated rats (Fig. 4b) which were strongly positive for rabbit IgG
(Fig. 4c). The anti-MCP staining was developed with a FITC
labeled rabbit anti-mouse antibody (No. F. 26102, Dakopatts).
Rat C3 was stained with an FITC labeled goat anti-rat C3
antibody (Nordic, Tilborg, The Netherlands). To stain for
macrophages frozen tissues were cut and stained with a mono-
clonal antibody directed against the monocyte specific cytoplas-
matic marker ED-i [39]. Fluorescence labeled second antibod-
ies were used to detect antibody binding. Appearance of ED-i
positive cells in glomeruli was assessed in a blinded fashion.
One kidney section of each animal at the different time points
and from CVF treated or untreated rats after intravenous
injection of the antibody (N = 5) and of control animals (N = 5)
was analyzed. The total number of glomeruli evaluated at each
time point varied between 120 and 164. The number of ED-i
positive cells are given per glomerular cross section as means
SEM.
Semiquantitative evaluation of MCP-1 expression by
immunohistology
A semiquantitative analysis for glomerular MCP-i was per-
formed in tissue section, stained with anti-MCP- 1. For this
Table 1. Distribution of epithelial and mesangial cells, and
monocytes/macrophages in isolated glomeruli from control and
nephritic rats
Epithelial cells Mesangial cells M/M
% of total cells
Control rats 13.0 2.3 22.2 3,7 3.1 0.9
Nephritis 30 mm 6.7 1.7° 17.0 4.6 7.5 2.6a
Nephritis 24 hr 10.4 2.4 5.3 1.8° 17.0 4.3°
Nephritis 5 days 8.2 3.l 28.0 2.3 13.2 3.0
Nephritis 3 weeks 6.7 2.o 20.8 2.7 14.5 2.6°
Induction of disease significantly reduced the relative number of
mesangial cells at 24 hours. Mesangial cells increased at 5 days and
returned to control values at 5 days and 3 weeks. There was a relative
decrease in the number of epithelial cells at 30 mm, 5 days, and 3 weeks,
whereas MIM were elevated in all nephritic rats. The remaining cells
were endothelial cells.
a P < 0.05 vs. control
purpose all glomeruli of a kidney section were analyzed by one
of us after blinding of the slides. Three animals of the control
group and the different time points after antibody were analyzed
with the application of the following scale: "0" = negative
stajn, (+) = weak glomerular stain, "+" = strong glomerular
stain, "++" = very strong glomerular stain. A mean of 127
16 glomeruli was evaluated at each time point and in controls.
The number of glomeruli for each scale was evaluated for the
animal groups and the intensity is expressed as the scale for
most glomeruli which stained.
Light microscopy
For light microscopy, tissue was fixed in 4% buffered form-
aldehyde and embedded in paraffin. Kidney sections were
stained with PAS.
Statistical analysis was performed with the unpaired Stu-
dent's 1-test with comparison of multiple variants when appli-
cable [40]. A P value of < 0.05 was considered significant.
Results
Relative appearance of glomerular mesangial and epithelial
cells in control and nephritic glomeruli
The evaluation of glomerular resident mesangial and epithe-
hal cells and monocytes/macrophages in the cell suspensions
prepared from isolated glomeruhi is summarized in Table 1.
Fig. 1A. Northern blot analysis of RNA extra cted from cell suspensions of isolated glomeruli and hybridized with cDNA probes of MCP-1/JE and
CSF-1. RNA was extracted from glomeruli isolated from control rats (0 time) and from rats that had been injected with antiserum (ATS) 30 minutes,
I or 5 days or 3 weeks prior to glomerular isolation. Levels of mRNA for CSF-1 (4.2 KB) remained unchanged. At 0 time mRNA for JE/MCP-l
were barely detectable, increased markedly after 30 minutes, were lower at 24 hours and then increased again. Comparable results were obtained
in two independent series of experiments. Densitometric analysis of mRNA levels revealed a 2.8-fold increase at 30 mm and no change at 24 hours
when compared with control, and a 1.8-and 1.7-fold increase at 5 days and 3 weeks, respectively. No consistent changes were observed for CSF-1.
B. Decomplementation of rats with cobra venom factor markedly suppressed the mRNA levels for JE/MCP- I in response to antiserum (ATS +
decompl.) as compared to antiserum alone (ATS) in glomeruli isolated after 30 minutes or 24 hours. Densitometry of the mRNA levels of MCP-l
demonstrated that CVF treated rats averaged 0.65-fold at 30 mm and 0.98-fold at 24 hours when compared with rats after ATS alone. C. Treatment
with non-immune serum and/or cobra venom factor had no effect on mRNA levels for CSF-1 in isolated glomeruli. No mRNA for JE/MCP-1 was
detectable under these conditions. Lane 1: control; Lane 2: non-immune serum 30 minutes; Lane 3: non-immune serum and cobra venom factor
30 minutes; Lane 4: non-immune serum 24 hours; LaneS: non-immune serum and cobra venom factor 24 hours. D. Northern blot analysis of RNA
extracted directly from isolated whole glomeruhi from normal (control) and nephritic animals (30 mm after ATS). Increased expression of MCP-l
in the diseased glomeruli (30 mm after ATS) again is demonstrated, indicating independence of results from the method of RNA extraction from
glomeruli. Densitometry of the Northern blots revealed a 1.8-fold increase in the MCP-l message at 30 minutes compared with controls.
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Fig. 2. Immunohistologic stain for ATS at 30
minutes (A) shows positivity, selective for the
mesangium. Twenty-four hours after the
intravenous antibody injection, the glomeruli
reveal severe mesangiolysis (B). After 5 days
glomeruli show the characteristics of a
proliferative glomerulonephritis (C).
When compared with controls the induction of nephritis de-
creased the number of mesangial cells (determined by Thy 1.1
antigen expression) at 24 hours, followed by a return towards
control numbers after five days to three weeks. In contrast to
mesangial cells, the relative amount of epithelial cells decreased
at 30 minutes, returned to control at 24 hours, and fell slightly
again at five days and three weeks. The relative amount of
monocytes/macrophages increased at 30 minutes, reached a
maximum at 24 hours and remained elevated until three weeks
after injection of the antibody.
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Fig. 2. Continued.
Northern blot analysis and morphologic characteristics
The Northern blot analysis from normal and nephritic gb-
meruli demonstrates marked differences in the steady-state
mRNA levels of MCP-l (Fig. la), whereas the expression of
CSF-l appeared to be stable. In glomeruli from control rats or
rats injected with non-immune serum, mRNA for MCP-l was
barely detectable or absent (Fig. la). Thirty minutes after the
injection of the ATS, levels of mRNA for MCP-l increased.
Morphologically this time point is associated with the in situ
immune complex formation in the mesangium (Fig. 2a). The
mRNA level of MCP- 1 decreased at 24 hours after the antibody
injection. Light microscopic studies at that time demonstrated
mesangiobysis (Fig. 2b). Five days and three weeks after the
induction of the disease the gbomerular mRNA levels of MCP- 1
increased again. Morphologically at days 5 and 21 glomeruli
showed the characteristic mesangial proliferative disease (Fig.
2c). In contrast to these changes in mRNA levels for MCP-l,
hybridization for CSF-l remained constant on the Northern blot
from control and ATS-injected rats after 30 minutes to three
weeks (Fig. ba). Equal loading of the different lanes is evi-
denced by comparable staining of the 18 and 28S RNA levels
(Fig. la). These data were further validated by laser densitom-
etry. Comparable results were obtained in two to three sets of
experiments for each time point. The increase in mRNA for
MCP-1 observed in RNA preparations from cell suspensions of
isolated glomeruli (Fig. la) was also demonstrated when RNA
was directly extracted from isolated glomeruli (Fig. id). When
rats were decomplemented by injection of cobra venom factor
prior to ATS administration, only a minor increase in mRNA
for CSF-1 was detectable after 30 minutes and 24 hours as
compared to gbomeruli from rats injected with ATS antiserum
only (Fig. ib). Decomplementation prevented the increase in
mRNA for MCP-l otherwise observed after 30 minutes of ATS
injection (Fig. ib). Injection of non-immune serum alone or
after cobra venom factor had no effect on the mRNA levels for
CSF-l and no mRNA for MCP-1 was detectable (Fig. ic). Thus,
the increase in mRNA for MCP-l is dependent on ATS and
complement.
Immunohistology for MCP-1
Immunohistology of kidneys from control rats showed faintly
positive staining for MCP- I in the glomerulus with a mesangial
distribution (Fig. 3a). At 30 minutes after injection of ATS
staining for MCP- I in glomeruli was increased as compared to
control gbomeruli (Fig. 3b), but faded at 24 hours after ATS
injection, the time of mesangiolysis (not shown). At 21 days
after induction of the nephritis the immunofluorescence for
MCP- 1 was again increased (Fig. 3c). At all time points the
immunofluorescence for MCP-l was predominantly apparent in
the glomerular mesangium, with a possibly faint additional
Fig. 3. Immunohistologic staining of normal
rat kidney tissue shows faint reaction for
MCP-1 in glomeruli and in the interstitium
(A). In the glomerulus immunohistology is
positive in the mesangium and along the
capillary wall, which probably corresponds to
the endothelium. The expression of MCP-l in
the glomeruli is markedly increased 30
minutes after the ATS antibody injection (B)
and the immunohistologic stain is strongest at
21 days (C). The pretreatment of rats with
cobra venom factor prevented the increased
expression of MCP-1 in glomeruli at 30
minutes after induction of ATS nephritis (D).
staining of endothelial cells. When rats had been complement
depleted by pretreatment with CVF, the glomerular staining for
rat C3 was almost negative 30 minutes after ATS injection (Fig.
4b) when compared to the C3 staining in rats with intact
complement system (Fig. 4a). In contrast to the complement
intact rats (Fig. 3b), injection of ATS antibody into decomple-
mented rats resulted in essentially negative staining for MCP-!
at 30 minutes (Fig. 3d) and 24 hours (not shown). CVF
treatment had no effect on ATS binding to the mesangium (Fig.
4c). Thus, in situ immune complex formation in the absence of
complement did not activate expression of MCP- 1.
The semiquantitative assessment of the immunohistology
revealed the strongest MCP-l expression at 30 minutes and
three weeks after ATS. The expression of MCP-i was reduced
after CVF treatment (Table 2).
Presence of glomerular monocytesimacrophages (MIM) in
glomeruli
The evaluation of M/M present in glomeruli by ED-i staining
revealed that the number of M/M significantly increased within
30 minutes following ATS injection, reached a maximum at 24
hours and remained elevated up to three weeks after induction
of the nephritis (Table 3). The decomplementation of rats with
CVF, which prevented the expression of MCP-l also resulted in
a significant decline in the number of infiltrating ED! positive
cells in the glomeruli. M/M in glomeruli of CVF treated rats
averaged those seen in control animals (Table 4).
Discussion
Monocytes/macrophages (M/M) play a major role in glomer-
ular disease processes. The mechanisms responsible for the
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Fig. 3. Continued.
Table 2. Semiquantitative assessment of immunostains for MCP-l in
glomeruli of control and ATS rats
Control 0 - (+)
Nephritis 30 miii + +
Nephritis 30 mm + CVF 0 - (+)
Nephritis 24 hr 0 - (+)
Nephritis 5 days +
Nephritis 3 weeks + +
The semiquantitative analysis of the MCP-l stain in glomeruli re-
vealed a very strong positivity in most rat glomeruli 30 mm and 3 weeks
after ATS. Evaluations were performed on 127 16 glomeruli for each
time point from 3 rats in each group.
recruitment of M/M into injured glomeruli have not been
completely defined. Recent evidence suggests that monocyte
specific chemoattractant cytokine MCP-1 may play an impor-
tant role in the migration of monocytes into injured vascular
tissues [19, 41, 42]. Mesangial cells in culture produce MCP-l
which is stimulated by IgG immune complexes and inflamma-
tory cytokines such as IL-i, TNF-a and IFN-y. Furthermore,
PDGF also stimulates expression of MCP-1 [20, 27]. Recent
work from one of our laboratories has demonstrated that
reactive oxygen species may serve as the second messenger for
immune complex and cytokine-induced generation of MCP-l
[28]. This is of specific interest as IgG complexes, TNF-s and
complement can also increase generation of oxygen radicals by
cultured mesangial cells [43—45]. It was therefore of interest to
investigate whether the induction of the anti-thymocyte antiserum
mediated, complement-dependent mesangial glomemlonephntis
might be associated with changes in glomeriilar MCP-l formation.
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Fig. 4. Thirty minutes after the intravenous
injection of the ATS antibody, glomeruli and
parts of the interstitium stained positive for
C3 (A). When rats were decomplemented with
cobra venom factor prior to the induction of
the glomerulonephritis the stain for C3 in
glomeruli was almost negative (B), however,
decomplernentation did not affect ATS
antibody binding to the mesangium (C).
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Control 30 mm 1 day 5 days 21 days
Using Northern blot analysis and immunohistology we now dem-
onstrate enhanced expression of MCP- 1 in the mesangium of
glomeruli with a glomerulonephritis which is characterized by
mesangial immune complex formation and infiltration of M/M into
the glomerulus.
Thirty minutes following the injection of the heterologous
antiserum, the expression of MCP-1 on Northern blot is in-
creased several-fold. Levels of mRNA for MCP-l are lower at
24 hours and increase again at five and 21 days following
induction of the disease. The question arises how these changes
in MCP- 1 expression correlate with the time course of the
nephritis. The studied glomerulonephritis is characterized by in
situ immune complex formation between the injected antiserum
and an antigen expressed on mesangial cells. The local immune
complex formation results in complement activation and mes-
angiolysis [30]. The lysis of the mesangial cells is then followed
by their reappearance and proliferation leading to a mesangial-
proliferative nephritis at five and 21 days and an eventual
healing of the glomerulus. At 30 minutes the in situ immune
complex formation might play a role in the enhanced expression
of MCP-1 as immune complexes stimulate MCP-1 generation in
cultured mesangial cells [20]. In addition, the possibility has to
be considered that activation and release of inflammatory
cytokines, such as TNF-a, IL-I or PDGF from mesangial cells
or inflammatory cells (PMNs, platelets), might affect expression
of the chemoattractant MCP-1. We have recently found that the
expression of interleukin-l/3 in glomeruli is markedly enhanced
after the ATS injection (Stahl et al, manuscript in preparation).
Since the expression of MCP- 1 is up-regulated by TNF and
interleukin-1f3, the possibility exists that these cytokines might
also be involved in the increased intraglomerular expression of
MCP-1 as early as 30 minutes after antibody injection. This
early expression of MCP- 1 seems to be almost entirely depen-
dent on the local activation of the complement system with
consecutive cell injury. Decomplementation of rats by treat-
ment with cobra venom factor prior to antibody injection
prevented the increased expression of MCP- 1 and also inhibited
the infiltration of M/M into the glomerulus. Experiments from
one of our laboratories have identified oxygen radicals as
cellular messengers for induction of MCP-l [281. Thus, immune
complex initiated complement activation with free radical gen-
eration may be a common mechanism underlying generation of
MCP-l. Conceivably, expression of MCP-1 might also be
influenced by PDGF generated in this animal model. Recent
studies in the model of mesangial glomerulonephritis have
demonstrated a role for PDGF in the mediation of mesangial
cell proliferation in this disease [10, 11]. PDGF was the earliest
cytokine shown to stimulate the JE gene in the mouse [46],
which corresponds to the gene for human MCP-l [15]. How-
Nephritis
30 mm
30 mm
÷ CVF 24 hours
24 hours
+ CVF
3.68 1.75
P<0.05
1.64 0.98 6.7 0.80a 2.70 0.13
P<0.001
The pretreatment of rats with cobra venom factor reduced the
number of ED! positive cells which appeared in the glomeruli at 30 mm
and 24 hours after induction of the nephritis by antibody injection. The
number of ED-I positive cells were significantly higher at 24 hours after
injection of ATS as compared to 30 mm. Results are means SEM from
5 rats (120 to 164 glomeruli evaluated) per experimental group.
a p < 0.001 vs. Nephritis 30 minutes
ever, PDGF is an unlikely candidate for the enhanced early (30
mm) expression of MCP- 1, as PDGF is only increased 24 hours
after ATS injection [10]. Whatever the factors responsible for
the increased glomerular expression of MCP- 1 at 30 minutes
may be, the association with glomerular M/M accumulation
demonstrated by ED- 1 positive cells invites the speculation of a
causal relationship between MCP-l and MIM accumulation.
Analysis by Northern blot and immunofluorescence shows
that MCP-1 is reduced at 24 hours after induction of nephritis.
At that time point glomeruli show severe mesangiolysis so that
the reduction of mRNA and immunohistologic staining for
MCP-1 is likely due to the destruction of mesangial cells.
Furthermore, the evaluation of the glomerular cell suspensions
revealed that mesangial cells are not abundant at that time
point. Together these findings strongly implicate the mesangial
cell as the major source of intraglomerular and even renal
MCP-l. This, however, does not exclude the possibility that
other cells, that is, macrophages, might express MCP-l. If one
considers, however, that at 24 hours M/M infiltration into the
glomerulus reaches a maximum whereas at that time MCP- 1
expression is rather low, it appears unlikely that MIM are a
major source of MCP-l. At 5 and 21 days, the expression of
MCP-l increased again. Light microscopy now reveals a mes-
angial proliferative glomerulonephritis. By immunohistology,
the increase in MCP-1 is again predominantly in the mes-
angium. At this time the mechanisms responsible for increased
MCP-1 expression might be multifactorial and could certainly
include increased PDGF generation [10, 46]. In this late phase
of the disease process, formation of intraglomerular immune
complexes is an unlikely contributing factor, since at this time
point immunostaining for ATS antibodies is almost negative.
The increased expression of intraglomerular MCP- 1 was
associated with an increased appearance of ED-l positive
monocytes/macrophages in the glomeruli. The fact that MCP-1
declined after 24 hours while M/M accumulation persisted does
not argue against a potential cause-effect relationship. MCP-1
need only contribute to the initial recruitment of M/M into the
nephritic glomerulus and their activation. Once activated the
M/M could remain sequestered in the glomerulus due to, for
example, adhesion molecule expression [47]. In this late phase
the M/M may play a role in the remodeling and healing process.
In this sense, the chemoattractant activity of MCP-l might play
a pivotal role in the initiation of the M/M dependent pathophys-
iology of glomerular disease. It is of interest that glomerular
mRNA levels for the monocyte CSF-l remained essentially
Table 3. ED-I positive cells/glomerular cross section
1.72 0.19 4.3 0.9a 5.9 0.3a 5.1 0.7a 4.5 0.6a
Induction of glomerular disease was followed by a significant increase
of ED-i positive cells in glomeruli when compared with control
animals. At each time point 145 16 glomeruli from 5 rats per group
were analyzed in a blinded fashion as outlined in Methods.
a p < 0.05 vs. control
Table 4. ED! positive cells/glomerular cross section
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unchanged during the entire course of the ATS nephritis as
compared to controls. This is consistent with a role of CSF-1 in
monocyte survival, but argues against a major role for CSF-l in
the recruitment of M/M to sites of inflammation. As no cone-
lation was apparent between the number of mesangial cells,
which are diminished at 24 hours and are markedly increased at
five and 21 days, it is unlikely that the mesangial cell is the
major source of CSF-l in this model of nephritis. Possibly,
endothelial cell expression of CSF-l is responsible for the
steady levels of mRNA for CSF-l in the glomeruli.
In summary, our results show rapid expression of glomerular
mesangial MCP-l associated with M/M accumulation in the
glomeruli of rats with ATS nephritis. We speculate that MCP-l
may be a chemotactic factor contributing to M/M recruitment in
glomerulonephritis, a hypothesis that deserves further testing.
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